Find out more about our subscription products and services by visiting our websites: CorporateHealthcareEnergy
Report Store

Search Within Market Intelligence

Keywords:
Search In
Industry:
Pub Month: From  To 
Price Range ($): Min       Max
 
 
 
 
Free Research Alert
Sign up for updates on the latest research
Email: 
 
 
Call us now on +44 1204 543 529
to speak to an advisor
 

Biovest International, Inc. (BVTI) - Financial and Strategic SWOT Analysis Review

Published: Jan-2013    Report Format:
Company Report
Single User License
Single User License
$125
Site License
Site License
$250
Global License
Global License
$375
 
 
Save time and money with a subscription
 
Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?
 
To find out more, click here or call +44 1204 543 545.
 
 
Biovest International, Inc. (Biovest), formerly known as Cellex Biosciences, Inc., is a specialty biopharmaceutical company focusing in the field of active personalized immunotherapies. The company’s activities are focused on developing BiovaxID and potentially other B-cell blood cancer vaccines; manufacturing and sale of AutovaxID and other instruments and consumables; and commercial production of cell culture products and services. BiovaxID is an under development patient-specific therapeutic cancer vaccine for treating non-Hodgkin’s lymphoma (NHL) with a special focus on follicular lymphoma, mantle cell lymphoma and other B-cell cancers. AutovaxID is an n automated cell culture instrument utilized for production of wide range of personalized medicines. The company also provides its customers with broad range of instruments and disposables to be utilized in hollow fiber production of cell culture products. Biovest has a bio-manufacturing facility based in Minneapolis, Minnesota. Biovest is a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. Biovest is headquartered in Tampa, Florida, the US. The company’s R&D activities are focused on successful commercialization of its products and technologies. This intent is reflected from the recent agreement with Max Planck Institute for Dynamics of Complex Technical Systems for studies related to influenza virus, as well as orphan drug designation for Revimmune and BiovaxID. This comprehensive SWOT profile of Biovest International, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weaknesses, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key operational centers and subsidiaries of the company, including contact details.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with five-year history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from five quarterly/semi-annual financial statements published by the company during the interim period.
  • Note: Some sections may be missing if the company’s data is unavailable.

Reasons To Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated into the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers based on the analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. It analyzes the company’s core strengths, weaknesses, opportunities and threats, providing you with an up-to-date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, financial and operational performance.
  • Financial ratios presented for major public companies in the report include revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
© GlobalData 2014. John Carpenter House, 7 Carmelite Street, London EC4 O85.